Issue 2, 2016

Novel heterocyclic ring-fused oleanolic acid derivatives as osteoclast inhibitors for osteoporosis

Abstract

Osteoporosis is a major public health problem in our aging society. In the present study, a series of novel oleanolic acid (OA) derivatives were synthesized via modifications in the A-ring and C-28 position of OA, and their anti-bone resorption activities were evaluated. Screening results revealed that most of the derivatives inhibited RANKL-induced osteoclast formation from RAW264.7 cells. Among the derivatives, 6g exhibited a potent inhibitory activity with an IC50 of 24 nM. Furthermore, 6g prevented ovariectomy-induced bone loss in rats. The preliminary mechanism investigation demonstrated that 6g suppressed the protein and mRNA expressions of c-Fos and NFATc1, and downregulated the mRNA of other osteoclastogenic markers. The results suggested that the OA derivatives might serve as potential leads for the development of novel agents for the treatment of osteoporosis.

Graphical abstract: Novel heterocyclic ring-fused oleanolic acid derivatives as osteoclast inhibitors for osteoporosis

Supplementary files

Article information

Article type
Research Article
Submitted
17 Oct 2015
Accepted
22 Dec 2015
First published
23 Dec 2015

Med. Chem. Commun., 2016,7, 371-377

Author version available

Novel heterocyclic ring-fused oleanolic acid derivatives as osteoclast inhibitors for osteoporosis

J. Wu, B. Bao, Q. Shen, Y. Zhang, Q. Jiang and J. Li, Med. Chem. Commun., 2016, 7, 371 DOI: 10.1039/C5MD00482A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements